The American Society of Gene & Cell Therapy
The American Society of Gene & Cell Therapy reported $16.9 million in revenue and $14.6 million in expenses for calendar year 2024. Of every $100 it spent, $80.12 went to program services, $14.24 to management and general costs and $5.64 to fundraising. Its largest source of revenue was program service revenue such as fees, sales and contracts: 92.4% of the total. The highest compensation it reported for one person was $618,447 (EXECUTIVE DIRECTOR). 6 people received more than $100,000 in reportable compensation. Revenue rose 160% between 2019 and 2024. Source: Form 990, 2024.
Where $100 of spending went
Calendar year 2024 · Form 990, Part IX, line 25 · total expenses $15MFor context, the median across 169 covered medical research charities: $87.02 programs, $12.87 management, $0.11 fundraising (medians computed separately, so they may not sum to $100).
Where $100 of revenue came from
Calendar year 2024 · Form 990, Part VIII · total revenue $17MThe 990 scorecard · same measures for every charity, no grades
| Measure | 2024 | Median |
|---|---|---|
| Program services Part IX 25(B) ÷ 25(A) | 80.1% | 83.9% |
| Management & general Part IX 25(C) ÷ 25(A) | 14.2% | 12.4% |
| Fundraising Part IX 25(D) ÷ 25(A) | 5.6% | 0.1% |
| Fundraising cost per $1 of contributions Part IX 25(D) ÷ Part VIII 1h | Not reported | $0.01 |
| Contributions & grants share of revenue Part VIII 1h ÷ 12 | 1.4% | 72.7% |
| Government grants share of revenue Part VIII 1e ÷ 12 | 0.0% | 0.0% |
| Program service revenue share Part VIII 2g ÷ 12 | 92.4% | 5.8% |
| Highest reported compensation Part VII-A, columns D–F | $618,447 | $628,890 |
| Highest compensation as share of expenses Part VII-A ÷ Part IX 25(A) | 4.24% | 1.94% |
| People paid over $100,000 Part VII, line 2 | 6 | 18 |
| Net assets, in months of expenses Part X 33(B) ÷ monthly expenses | 16.7 | 13.3 |
| Independent voting board members Part VI 1a–1b | 15 of 15 | 93.8% |
A median is context, not a target: hospitals, universities, food banks and grantmakers spend in very different ways. What these measures can and can't tell you.
What the money paid for, in its own words
2024 · Form 990, Part III · the three largest programs by expenseAnnual meeting: this is the primary vehicle for carrying out the educational mission of asgct. The annual meeting represents the major educational initiative of the society
Molecular therapy journals: publishing scholarly journals is the second major vehicle for carrying out the educational mission of asgct. The journals are the way asgct educates and updates researchers, clinicians, and students on the latest advances in the development of novel therapeutics
Advocacy: advocacy is the third major vehicle for carrying out the educational mission of asgct. The defining value of advocacy is "Gene and Cell therapy will have a financial impact on patients, providers, and payers. Asgct is committed to understanding that impact and educating decision-makers engaged in developing policies that influence patient access to treatments."
Highest reported compensation
2024 · Form 990, Part VII, Section A · roles as filed; names are in the filing, not here| Role | From this org | From related orgs | Other | Total |
|---|---|---|---|---|
| EXECUTIVE DIRECTOR Officer, 40.00 hrs/week | $577,778 | $0 | $40,669 | $618,447 |
| EMPLOYEE Highest compensated employee, 40.00 hrs/week | $242,394 | $0 | $7,272 | $249,666 |
| EMPLOYEE Highest compensated employee, 40.00 hrs/week | $215,407 | $0 | $15,816 | $231,223 |
| EMPLOYEE Highest compensated employee, 40.00 hrs/week | $169,899 | $0 | $14,949 | $184,848 |
| EMPLOYEE Highest compensated employee, 40.00 hrs/week | $153,501 | $0 | $19,493 | $172,994 |
| EMPLOYEE Highest compensated employee, 40.00 hrs/week | $139,261 | $0 | $24,148 | $163,409 |
6 people received more than $100,000 in reportable compensation from The American Society of Gene & Cell Therapy (Part VII, line 2). Compensation of current officers, directors and key employees totaled $618K (Part IX, line 5).
6 years of filings
Form 990, Parts I, VII, IX and X · each row is that year's own filing, linkedGovernance answers, as filed
2024 · the organization's own yes/no answers; explanations, if any, are in Schedule O of the filing · what each means- Voting board members, and how many are independent Part VI, lines 1a–1b15 · 15 independent
- Audited financial statements Part XII 2bYes
- Conflict-of-interest policy Part VI 12aYes
- Whistleblower policy Part VI 13Yes
- Document retention policy Part VI 14Yes
- Independent process for top executive pay Part VI 15aYes
- Board given the 990 before filing Part VI 11aYes
- Family or business ties among insiders Part VI 2No
- Aware of a significant diversion of assets Part VI 5No
- Excess benefit transaction with an insider Part IV 25aNo
- Loans to or from insiders outstanding Part IV 26No
- Lobbying, or a 501(h) election in effect Part IV 4No
- Over $15,000 of professional fundraising services Part IV 18No
- Over $10,000 of activity outside the U.S. Part IV 14bYes
- Employees Part I, line 548
- Volunteers Part I, line 619
Largest outside contractors
2024 · Form 990, Part VII, Section B · businesses only| BGR GOVERNMENT AFFAIRS LLC Advocacy | $216,000 |
Individuals listed as contractors are left out. 1 contractors were paid more than $100,000 in all.
Private foundation grants it received
2 private foundations reported grants to The American Society of Gene & Cell Therapy totaling $10,021 on their tax year 2023 Form 990-PF returns. See which foundations, on WHOFUNDS.
Source: WHOFUNDS open grant graph, matched from Form 990-PF Part XV.
Correct a figure or respond
Every number above is copied from The American Society of Gene & Cell Therapy's own Form 990. If one doesn't match the filing, that's our error and we'll fix it. If you work for The American Society of Gene & Cell Therapy, you can publish a response that is linked from this page.
Share or embed this breakdown
Of every $100 The American Society of Gene & Cell Therapy spent in 2024, $80.12 went to programs. The full breakdown, from its IRS Form 990:
Embed on your site
Similar-sized charities in this cause
- Sanders Tri-Institutional Therapeutics Discovery Institute Inc. Co Weill CornelNew York, NY · revenue $17M · programs 92.9% · 2024
- The American Academy of Allergy AsthmaMilwaukee, WI · revenue $18M · programs 63.2% · 2024
- William K Warren Medical Research CenterTulsa, OK · revenue $16M · programs 64.8% · 2024
- Movember FoundationSanta Monica, CA · revenue $18M · programs 72.1% · FY2026
- ALS Therapy Development FoundationWatertown, MA · revenue $16M · programs 90.5% · 2025
All medical research charities · Largest charities in Wisconsin
Questions people ask
How much of The American Society of Gene & Cell Therapy's spending goes to programs?
In calendar year 2024, The American Society of Gene & Cell Therapy reported that 80.1% of its $14.6 million in expenses went to program services, 14.2% to management and general and 5.6% to fundraising (Form 990, Part IX).
How much does The American Society of Gene & Cell Therapy pay its top executive?
The largest total compensation The American Society of Gene & Cell Therapy reported for one person in calendar year 2024 was $618,447, for the role of EXECUTIVE DIRECTOR (Form 990, Part VII, including compensation from related organizations and other compensation).
Where does The American Society of Gene & Cell Therapy get its money?
Of $16.9 million in revenue in calendar year 2024, 1.4% came from contributions and grants and 92.4% from program service revenue (Form 990, Part VIII).
Is The American Society of Gene & Cell Therapy a registered charity?
The IRS lists EIN 91-1766321 as a 501(c)(3) organization (publicly supported organization (170(b)(1)(a)(vi))), and its records show contributions as tax-deductible. Form 990 filings on record here cover tax years 2019, 2020, 2021, 2022, 2023, 2024. A filing shows what the organization reported; it doesn't by itself show whether a program works.
Sources
- 2024: Form 990 for calendar year 2024, object 202503219349319690 · read the filing · XML
- 2023: Form 990 for calendar year 2023, object 202413099349303011 · read the filing
- 2022: Form 990 for calendar year 2022, object 202343139349301974 · read the filing
- 2021: Form 990 for calendar year 2021, object 202222949349301327 · read the filing
- 2020: Form 990 for calendar year 2020, object 202133169349302343 · read the filing
- 2019: Form 990 for calendar year 2019, object 202043189349308149 · read the filing
All filings for EIN 91-1766321: ProPublica Nonprofit Explorer · IRS Tax Exempt Organization Search. Figures are as the organization reported them; we have not audited them.